阿里影業(01060.HK)IP交易平台「阿里魚」累計與近萬家品牌及渠道商達成合作
阿里影業(01060.HK)旗下IP交易及創新平台阿里魚發布2024年消費品與營銷項目授權報告,透露自2016年成立以來,該平台一直圍繞IP授權及消費產業鏈上下游進行探索,創建特有的「IP2B2C」全鏈路服務模式,累計已經與數百個國內外優質IP,以及近萬家品牌及渠道商家達成合作。
阿里文娛副總裁兼阿里魚總裁吳倩表示,充分借助阿里巴巴(09988.HK)生態的豐富資源與數字能力,令阿里魚可以為合作商家提供IP合作全鏈路專業服務,並幫助版權方提升IP商業價值,實現多元化增值目標。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.